Markets
Alphabet CEO Sundar Pichai speaks at conference
Alphabet CEO Sundar Pichai speaks at conference (Photo by ANDREW CABALLERO/Getty Images)

Alphabet makes more in interest income than most S&P 500 companies earn in total

$1 billion in three months, to be exact

It’s hard to overstate the earnings power of Big Tech. After all, that’s how you get to be Big Tech (outside of Tesla, I suppose).

These companies’ immense profitability is directly linked to the dominant positions they have in industries that are either huge to begin with or growing faster than the rest of the economy. Think things like Alphabet’s search, Apple’s phones, or Amazon’s web services.

What might not be very well appreciated is how profits produced through that industry leadership have a flywheel effect. Besides giving money back to shareholders, engaging in M&A activity, or trying to create the Next Big Thing, tech giants can also make stacks of cash just by investing their retained earnings – typically in short-term US Treasuries or corporate bonds.

One highlight from Alphabet’s latest quarterly report is that the company made over $1 billion in net interest income for the three months ending in June.

397 companies in the S&P 500 didn’t make that much in total net income in their most recent quarter – a group that includes firms like Target, Starbucks, Advanced Micro Devices, Marriott, and Blackstone.

And if we strip out the ones that posted net losses (since these can be driven by extenuating circumstances like acquisitions), Alphabet still made more in interest than the bottom 30 earners in the S&P 500 made in total profits combined!

Alphabet’s net interest income has more than doubled over the past three years, while its net income is up less than 30% over the same period.

Obviously, the Federal Reserve’s fingerprints are all over this. It’s easier to sit around and make money doing nothing when you get paid more for sitting around, having money in short-term fixed income securities, and clipping coupons.

Interest rates are typically thought of as a tool of macroeconomic stabilization: turn the dial up, economy goes down; turn the dial down, the economy goes up. But this exercise helps reinforce that interest rates can have distributional consequences that can be far more momentous than any “headline” impacts that show up in things like GDP growth.

This is true both in the household and corporate sectors. Weaker companies tend to have more floating-rate debt and are exposed to higher interest costs as rates rise, while the stronger companies…well, see above. People who are less-well off tend to have more debt; richer people tend to own more interest-bearing assets

This phenomenon is also a reminder of how flimsy and volatile our narratives around price action can be (including, in all likelihood, ones espoused here). Back in 2018, when the 10-year Treasury yield surged above 3% (how quaint!), the Nasdaq 100 materially underperformed the S&P 500 during the accompanying market downturn. The thinking was, in part, that richly valued megacap firms were more exposed to a valuation reset brought about by higher rates.

Snap back to the present day, and Big Tech is raking in billions on higher rates and we’re looking primarily for lower borrowing costs to put a floor under more cyclical parts of the economy.

It’s markets. We’re all trying to put together a puzzle whose pieces change in shape and size every few weeks, and we never got the picture on the front of the box showing what it’s supposed to be anyway.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets
Luke Kawa

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.